Clinical trial
A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
NCT07697456 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Lead sponsor
- AbbVie
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- July 31, 2026
- Completion date
- October 31, 2031
- Enrollment
- 2,000 (estimated)
- Sites
- 63
Conditions
As the registry lists them; a condition with its own page is linked.
crohn's disease, ulcerative colitis